Background Certain immune-mediated diseases (IMDs), such as rheumatoid arthritis and systemic lupus erythematosus, have been linked to cardiovascular disorders. We examined whether there is an association between 32 different IMDs and risk of subsequent hospitalization for coronary heart disease (CHD) related to coronary atherosclerosis in a nationwide follow up study in Sweden. Methods and Findings All individuals in Sweden hospitalized with a main diagnosis of an IMD (n = 336,479) without previous or coexisting CHD, between January 1, 1964 and December 31 2008, were followed for first hospitalization for CHD. The reference population was the total population of Sweden. Standardized incidence ratios (SIRs) for CHD were calculated. Overall risk of CHD during the first year after hospitalization for an IMD was 2.92 (95% CI 2.84–2.99). Twenty-seven of the 32 IMDs studied were associated with an increased risk of CHD during the first year after hospitalization. The overall risk of CHD decreased over time, from 1.75 after 1–5 years (95% CI 1.73–1.78), to 1.43 after 5–10 years (95% CI 1.41–1.46) and 1.28 after 10+ years (95% CI 1.26–1.30). Females generally had higher SIRs than males. The IMDs for which the SIRs of CDH were highest during the first year after hospitalization included chorea minor 6.98 (95% CI 1.32–20.65), systemic lupus erythematosus 4.94 (95% CI 4.15–5.83), rheumatic fever 4.65 (95% CI 3.53–6.01), Hashimoto's thyroiditis 4.30 (95% CI 3.87–4.75), polymyositis/dermatomyositis 3.81 (95% CI 2.62–5.35), polyarteritis nodosa 3.81 (95% CI 2.72–5.19), rheumatoid arthritis 3.72 (95% CI 3.56–3.88), systemic sclerosis 3.44 (95% CI 2.86–4.09), primary biliary cirrhosis 3.32 (95% CI 2.34–4.58), and autoimmune hemolytic anemia 3.17 (95% CI 2.16–4.47). Conclusions Most IMDs are associated with increased risk of CHD in the first year after hospital admission. Our findings suggest that many hospitalized IMDs are tightly linked to coronary atherosclerosis.
Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868–874.
[3]
van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, et al. (2008) Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 47: 3–7.
[4]
Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nature Immunology 12: 204–212.
[5]
Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337–3347.
[6]
López-Pedrera C, Pérez-Sánchez C, Ramos-Casals M, Santos-Gonzalez M, Rodriguez-Ariza A, et al. (2012) Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions. Clin Dev Immunol. doi:10.1155/2012/974648.
Lévy L, Fautrel B, Barnetche T, Schaeverbeke T (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 26: 673–679.
[10]
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, et al. (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107: 1303–1307.
[11]
Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121: S9–S14.
[12]
Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121: S21–S31.
[13]
Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145: 408–415.
[14]
Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, et al. (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349: 2407–2415.
[15]
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, et al. (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349: 2399–2406.
[16]
Vaudo G, Bocci EB, Shoenfeld Y, Schillaci G, Wu R, et al. (2005) Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 52: 3890–3897.
[17]
van Leuven SI, Hezemans R, Levels JH, Snoek S, Stokkers PC, et al. (2007) Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res 48: 2640–2646.
[18]
Vizzardi E, Raddino R, Teli M, Gorga E, Brambilla G, et al. (2010) Psoriasis and cardiovascular diseases. Acta Cardiol 65: 337–340.
[19]
Rosen M, Hakulinen T (2005) Use of disease registers. In: Ahrens W, Pigeot I, editors. Handbook of epidemiology. Springer-Verlag, Berlin. pp. 231–52.
[20]
The Swedish Hospital Discharge Register 1987–1996: quality and contents. (1998) National Board of Health and Welfare, Stockholm.
[21]
Rothman KJ, Greenland S (1998) Modern Epidemiology, Second Edition. Lippincott-Raven, Philadelphia.
[22]
O'Keefe JH, Carter MD, Lavie CJ (2009) Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 84: 741–757.
[23]
Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, et al. (2005) High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 94: 797–801.
[24]
Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, et al. (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 49: 295–307.
[25]
Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, et al. (2011) Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 50: 518–531.
[26]
Nationella riktlinjer f？r hj？rtsjukv？rd 2008. Beslutsst？d f？r prioriteringar. (2008) In Swedish. National Board of Health and Welfare, Stockholm.
[27]
Validity of the diagnoses from the Swedish In-Care Register 1987 and 1995. (2000) In Swedish. National Board of Health and Welfare, Stockholm.
[28]
Lindblad U, R？stam L, Ranstam J, Peterson M (1993) Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 21: 3–9.
[29]
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, et al. (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11: 450.
